SAFB1 Mediates Repression of Immune Regulators and Apoptotic Genes in Breast Cancer Cells*

The scaffold attachment factors SAFB1 and SAFB2 are paralogs, which are involved in cell cycle regulation, apoptosis, differentiation, and stress response. They have been shown to function as estrogen receptor corepressors, and there is evidence for a role in breast tumorigenesis. To identify their endogenous target genes in MCF-7 breast cancer cells, we utilized a combined approach of chromatin immunoprecipitation (ChIP)-on-chip and gene expression array studies. By performing ChIP-on-chip on microarrays containing 24,000 promoters, we identified 541 SAFB1/SAFB2-binding sites in promoters of known genes, with significant enrichment on chromosomes 1 and 6. Gene expression analysis revealed that the majority of target genes were induced in the absence of SAFB1 or SAFB2 and less were repressed. Interestingly, there was no significant overlap between the genes identified by ChIP-on-chip and gene expression array analysis, suggesting regulation through regions outside the proximal promoters. In contrast to SAFB2, which shared most of its target genes with SAFB1, SAFB1 had many unique target genes, most of them involved in the regulation of the immune system. A subsequent analysis of the estrogen treatment group revealed that 12% of estrogen-regulated genes were dependent on SAFB1, with the majority being estrogen-repressed genes. These were primarily genes involved in apoptosis, such as BBC3, NEDD9, and OPG. Thus, this study confirms the primary role of SAFB1/SAFB2 as corepressors and also uncovers a previously unknown role for SAFB1 in the regulation of immune genes and in estrogen-mediated repression of genes.

[1]  P. Karlsson,et al.  No germline mutations in supposed tumour suppressor genes SAFB1 and SAFB2 in familial breast cancer with linkage to 19p , 2008, BMC Medical Genetics.

[2]  Adrian V. Lee,et al.  Structure-function analysis of the estrogen receptor alpha corepressor scaffold attachment factor-B1: identification of a potent transcriptional repression domain. , 2004, The Journal of biological chemistry.

[3]  Thomas D. Schmittgen,et al.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. , 2001, Methods.

[4]  Steffi Oesterreich,et al.  Low SAFB levels are associated with worse outcome in breast cancer patients , 2010, Breast Cancer Research and Treatment.

[5]  A. Traweger,et al.  The Tight Junction Protein ZO-2 Localizes to the Nucleus and Interacts with the Heterogeneous Nuclear Ribonucleoprotein Scaffold Attachment Factor-B* , 2003, The Journal of Biological Chemistry.

[6]  S. Hilsenbeck,et al.  Global gene expression analysis of estrogen receptor transcription factor cross talk in breast cancer: identification of estrogen-induced/activator protein-1-dependent genes. , 2005, Molecular endocrinology.

[7]  L. Coussens,et al.  Paradoxical roles of the immune system during cancer development , 2006, Nature Reviews Cancer.

[8]  J. Auwerx,et al.  Scaffold attachment factor B1 directly interacts with nuclear receptors in living cells and represses transcriptional activity. , 2005, Journal of molecular endocrinology.

[9]  S. Keleş,et al.  Transcription of histone gene cluster by differential core-promoter factors. , 2007, Genes & development.

[10]  Adrian V. Lee,et al.  High rates of loss of heterozygosity on chromosome 19p13 in human breast cancer , 2001, British Journal of Cancer.

[11]  J. Russo,et al.  SATB1 reprogrammes gene expression to promote breast tumour growth and metastasis , 2008, Nature.

[12]  B. Katzenellenbogen,et al.  Selective recognition of distinct classes of coactivators by a ligand-inducible activation domain. , 2004, Molecular cell.

[13]  C. Osborne,et al.  HET/SAF-B overexpression causes growth arrest and multinuclearity and is associated with aneuploidy in human breast cancer. , 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.

[14]  S. Riva,et al.  Stress-induced nuclear bodies are sites of accumulation of pre-mRNA processing factors. , 2001, Molecular biology of the cell.

[15]  Barry Komm,et al.  Profiling of estrogen up- and down-regulated gene expression in human breast cancer cells: insights into gene networks and pathways underlying estrogenic control of proliferation and cell phenotype. , 2003, Endocrinology.

[16]  S. Jiang,et al.  Estrogen receptor corepressors -- a role in human breast cancer? , 2003, Endocrine-related cancer.

[17]  A. Chinnaiyan,et al.  Integrative analysis of the cancer transcriptome , 2005, Nature Genetics.

[18]  R. Grosschedl,et al.  SUMO modification of a novel MAR-binding protein, SATB2, modulates immunoglobulin mu gene expression. , 2003, Genes & development.

[19]  H. Niida,et al.  The MAR-binding protein SATB1 orchestrates temporal and spatial expression of multiple genes during T-cell development. , 2000, Genes & development.

[20]  T. Kohwi-Shigematsu,et al.  SATB1 packages densely looped, transcriptionally active chromatin for coordinated expression of cytokine genes , 2006, Nature Genetics.

[21]  F. Wright,et al.  Pooled analysis of loss of heterozygosity in breast cancer: a genome scan provides comparative evidence for multiple tumor suppressors and identifies novel candidate regions. , 2003, American journal of human genetics.

[22]  Kenny Q. Ye,et al.  Transcriptional signature with differential expression of BCL6 target genes accurately identifies BCL6-dependent diffuse large B cell lymphomas , 2007, Proceedings of the National Academy of Sciences.

[23]  Y. Moreau,et al.  Positional gene enrichment analysis of gene sets for high-resolution identification of overrepresented chromosomal regions , 2008, Nucleic acids research.

[24]  T. Kohwi-Shigematsu,et al.  An Atypical Homeodomain in SATB1 Promotes Specific Recognition of the Key Structural Element in a Matrix Attachment Region* , 1997, The Journal of Biological Chemistry.

[25]  O. Britanova,et al.  Novel transcription factor Satb2 interacts with matrix attachment region DNA elements in a tissue‐specific manner and demonstrates cell‐type‐dependent expression in the developing mouse CNS , 2005, The European journal of neuroscience.

[26]  C. Osborne,et al.  Scaffold attachment factor SAFB1 suppresses estrogen receptor alpha-mediated transcription in part via interaction with nuclear receptor corepressor. , 2006, Molecular endocrinology.

[27]  Adrian V. Lee,et al.  SAFB2, a New Scaffold Attachment Factor Homolog and Estrogen Receptor Corepressor* , 2003, Journal of Biological Chemistry.

[28]  Y. Benjamini,et al.  Controlling the false discovery rate in behavior genetics research , 2001, Behavioural Brain Research.

[29]  Adrian V. Lee,et al.  Novel nuclear matrix protein HET binds to and influences activity of the HSP27 promoter in human breast cancer cells , 1997, Journal of cellular biochemistry.

[30]  K. Korach,et al.  Estrogen receptors and human disease. , 2006, The Journal of clinical investigation.

[31]  Y. Kohwi,et al.  A tissue-specific MAR SAR DNA-binding protein with unusual binding site recognition , 1992, Cell.

[32]  A. Hartmann,et al.  SAF-B protein couples transcription and pre-mRNA splicing to SAR/MAR elements. , 1998, Nucleic acids research.

[33]  Andrew G. Clark,et al.  Genomic Analyses of Transcription Factor Binding, Histone Acetylation, and Gene Expression Reveal Mechanistically Distinct Classes of Estrogen-Regulated Promoters , 2007, Molecular and Cellular Biology.

[34]  F. O. Fackelmayer,et al.  Purification and molecular cloning of the scaffold attachment factor B (SAF-B), a novel human nuclear protein that specifically binds to S/MAR-DNA. , 1996, Nucleic acids research.

[35]  T. Kohwi-Shigematsu,et al.  SATB1 targets chromatin remodelling to regulate genes over long distances , 2002, Nature.

[36]  J. Cleveland,et al.  Puma is an essential mediator of p53-dependent and -independent apoptotic pathways. , 2003, Cancer cell.

[37]  Arul M Chinnaiyan,et al.  Genes regulated by estrogen in breast tumor cells in vitro are similarly regulated in vivo in tumor xenografts and human breast tumors , 2006, Genome Biology.

[38]  A. Dejean,et al.  Functional interaction between PML and SATB1 regulates chromatin-loop architecture and transcription of the MHC class I locus , 2007, Nature Cell Biology.

[39]  B. O’Malley.  Coregulators: from whence came these "master genes". , 2007, Molecular endocrinology.

[40]  J. Hansen,et al.  Recent Advances in Mecp2 Structure and Function Introduction: a Historical Perspective of Mecp2 Structure and Function , 2022 .

[41]  G. Biamonti,et al.  SAFB re-distribution marks steps of the apoptotic process. , 2007, Experimental cell research.

[42]  Adrian V. Lee,et al.  Disruption of scaffold attachment factor B1 leads to TBX2 up-regulation, lack of p19ARF induction, lack of senescence, and cell immortalization. , 2006, Cancer research.

[43]  S. Galande,et al.  The third dimension of gene regulation: organization of dynamic chromatin loopscape by SATB1. , 2007, Current opinion in genetics & development.

[44]  Marc E. Lippman,et al.  GREB1 is a critical regulator of hormone dependent breast cancer growth , 2005, Breast Cancer Research and Treatment.

[45]  Adrian V. Lee,et al.  Scaffold Attachment Factor B1 Functions in Development, Growth, and Reproduction , 2005, Molecular and Cellular Biology.

[46]  J. Venables,et al.  Alternative RNA splicing complexes containing the scaffold attachment factor SAFB2 , 2007, Journal of Cell Science.

[47]  C. Paweletz,et al.  Isolation and Characterization of SATB2, a Novel AT-rich DNA Binding Protein Expressed in Development- and Cell-Specific Manner in the Rat Brain , 2006, Neurochemical Research.